Neridronic acid for treating complex regional pain syndrome
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Oral dosage forms of osteoclast inhibitors, such as neridronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome.
Claims30
A method of treating complex regional pain syndrome (CRPS), comprising administering a total dose of 2000 mg or less of neridronic acid, in a salt form or an acid form, to a human being suffering from complex regional pain syndrome, in a single or divided doses, wherein the human being has a pain score of at least about 4 on the 0-10 numeric rating scale, wherein the CRPS was triggered by a traumatic event, and wherein the traumatic event was bone fracture.
The method of claim 7, wherein the neridronic acid is administered intravenously.
Dependencies are inferred from the claim text.